vs
Arcus Biosciences, Inc.（RCUS）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Arcus Biosciences, Inc.的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.5倍（$11.0M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -963.6%，领先961.6%），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -52.2%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-121.0M），过去两年Arcus Biosciences, Inc.的营收复合增速更高（4.9% vs 1.9%）
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
RCUS vs RMCF — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $7.5M |
| 净利润 | $-106.0M | $-155.0K |
| 毛利率 | — | 34.0% |
| 营业利润率 | -1036.4% | 1.1% |
| 净利率 | -963.6% | -2.1% |
| 营收同比 | -52.2% | -4.4% |
| 净利润同比 | -12.8% | 81.7% |
| 每股收益（稀释后） | $-0.88 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $11.0M | $7.5M | ||
| Q3 25 | $6.0M | $6.8M | ||
| Q2 25 | $8.0M | $6.4M | ||
| Q1 25 | $8.0M | $8.9M | ||
| Q4 24 | $23.0M | $7.9M | ||
| Q3 24 | $7.0M | $6.4M | ||
| Q2 24 | $11.0M | $6.4M | ||
| Q1 24 | $10.0M | $7.3M |
| Q4 25 | $-106.0M | $-155.0K | ||
| Q3 25 | $-135.0M | $-662.0K | ||
| Q2 25 | $0 | $-324.0K | ||
| Q1 25 | $-112.0M | $-2.9M | ||
| Q4 24 | $-94.0M | $-847.0K | ||
| Q3 24 | $-92.0M | $-722.0K | ||
| Q2 24 | $-93.0M | $-1.7M | ||
| Q1 24 | $-4.0M | $-1.6M |
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
| Q4 25 | -1036.4% | 1.1% | ||
| Q3 25 | -2366.7% | -7.0% | ||
| Q2 25 | -100.0% | -2.3% | ||
| Q1 25 | -1525.0% | -30.3% | ||
| Q4 24 | -447.8% | -8.9% | ||
| Q3 24 | -1500.0% | -14.3% | ||
| Q2 24 | -963.6% | -25.4% | ||
| Q1 24 | -160.0% | -21.7% |
| Q4 25 | -963.6% | -2.1% | ||
| Q3 25 | -2250.0% | -9.7% | ||
| Q2 25 | — | -5.1% | ||
| Q1 25 | -1400.0% | -32.5% | ||
| Q4 24 | -408.7% | -10.7% | ||
| Q3 24 | -1314.3% | -11.3% | ||
| Q2 24 | -845.5% | -25.9% | ||
| Q1 24 | -40.0% | -21.9% |
| Q4 25 | $-0.88 | $-0.02 | ||
| Q3 25 | $-1.27 | $-0.09 | ||
| Q2 25 | $0.00 | $-0.04 | ||
| Q1 25 | $-1.14 | $-0.38 | ||
| Q4 24 | $-1.07 | $-0.11 | ||
| Q3 24 | $-1.00 | $-0.11 | ||
| Q2 24 | $-1.02 | $-0.26 | ||
| Q1 24 | $-0.05 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.0M | $641.0K |
| 总债务越低越好 | $99.0M | — |
| 股东权益账面价值 | $631.0M | $6.0M |
| 总资产 | $1.1B | $20.7M |
| 负债/权益比越低杠杆越低 | 0.16× | — |
8季度趋势，按日历期对齐
| Q4 25 | $222.0M | $641.0K | ||
| Q3 25 | $238.0M | $2.0M | ||
| Q2 25 | $248.0M | $893.0K | ||
| Q1 25 | $192.0M | $720.0K | ||
| Q4 24 | $150.0M | $1.1M | ||
| Q3 24 | $201.0M | $973.0K | ||
| Q2 24 | $156.0M | $637.0K | ||
| Q1 24 | $185.0M | $2.1M |
| Q4 25 | $99.0M | — | ||
| Q3 25 | $98.0M | — | ||
| Q2 25 | $97.0M | — | ||
| Q1 25 | $48.0M | — | ||
| Q4 24 | $48.0M | — | ||
| Q3 24 | $47.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $631.0M | $6.0M | ||
| Q3 25 | $436.0M | $6.1M | ||
| Q2 25 | $549.0M | $6.7M | ||
| Q1 25 | $531.0M | $7.0M | ||
| Q4 24 | $485.0M | $9.8M | ||
| Q3 24 | $565.0M | $10.5M | ||
| Q2 24 | $635.0M | $9.0M | ||
| Q1 24 | $707.0M | $10.6M |
| Q4 25 | $1.1B | $20.7M | ||
| Q3 25 | $974.0M | $22.3M | ||
| Q2 25 | $1.1B | $20.1M | ||
| Q1 25 | $1.2B | $21.2M | ||
| Q4 24 | $1.1B | $21.6M | ||
| Q3 24 | $1.3B | $21.1M | ||
| Q2 24 | $1.2B | $19.0M | ||
| Q1 24 | $1.3B | $20.6M |
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-120.0M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-121.0M | $-1.3M |
| 自由现金流率自由现金流/营收 | -1100.0% | -16.9% |
| 资本支出强度资本支出/营收 | 9.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $-120.0M | $-1.2M | ||
| Q3 25 | $-97.0M | $-488.0K | ||
| Q2 25 | $-133.0M | $350.0K | ||
| Q1 25 | $-132.0M | $1.2M | ||
| Q4 24 | $-100.0M | $-2.1M | ||
| Q3 24 | $26.0M | $-3.5M | ||
| Q2 24 | $-94.0M | $-2.2M | ||
| Q1 24 | $-2.0M | $129.0K |
| Q4 25 | $-121.0M | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | — | $182.0K | ||
| Q1 25 | $-133.0M | — | ||
| Q4 24 | $-101.0M | — | ||
| Q3 24 | $25.0M | $-4.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $-6.0M | $-352.3K |
| Q4 25 | -1100.0% | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | -1662.5% | — | ||
| Q4 24 | -439.1% | — | ||
| Q3 24 | 357.1% | -72.6% | ||
| Q2 24 | — | -40.2% | ||
| Q1 24 | -60.0% | -4.9% |
| Q4 25 | 9.1% | 0.5% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 12.5% | — | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 14.3% | 17.5% | ||
| Q2 24 | 0.0% | 6.5% | ||
| Q1 24 | 40.0% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
